An open-label, 2-way crossover study of steady-state intragastric pH control comparing 2 dosage regimens of esomeprazole and lansoprazole in Barrett's esophagus patients
Phase of Trial: Phase IV
Latest Information Update: 17 Jul 2009
At a glance
- Drugs Esomeprazole; Lansoprazole
- Indications Barrett's oesophagus; Gastro-oesophageal reflux
- Focus Pharmacodynamics
- Sponsors AstraZeneca
- 17 Jul 2009 Results have been reported in Alimentary Pharmacology and Therapeutics.
- 19 Jun 2007 Status changed from in progress to completed.
- 14 Oct 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History